Page last updated: 2024-09-02

ecteinascidin 743 and Angiosarcoma

ecteinascidin 743 has been researched along with Angiosarcoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anand, A; Giri, GV; Govind Babu, K; Jacob, LA; Koppaka, D; Kumar, RV; Lakshmaiah, KC; Lokanatha, D; Lokesh, KN; Rajeev, LK; Rudresha, AH; Saldanha, SC; Suresh Babu, MC	1
Constantinidou, A; Jones, RL; Loggers, E; Pollack, S; Rodler, E	1

Reviews

1 review(s) available for ecteinascidin 743 and Angiosarcoma

Article	Year
The evolution of systemic therapy in sarcoma. Expert review of anticancer therapy, 2013, Volume: 13, Issue:2 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chordoma; Deoxycytidine; Dermatofibrosarcoma; Dioxoles; Docetaxel; Drug Resistance, Neoplasm; Gemcitabine; Hemangiosarcoma; Humans; Osteosarcoma; Proteasome Inhibitors; Receptor, IGF Type 1; Sarcoma; Soft Tissue Neoplasms; Taxoids; Tetrahydroisoquinolines; TOR Serine-Threonine Kinases; Trabectedin	2013

Article

Year

The evolution of systemic therapy in sarcoma.

Expert review of anticancer therapy, 2013, Volume: 13, Issue:2

Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chordoma; Deoxycytidine; Dermatofibrosarcoma; Dioxoles; Docetaxel; Drug Resistance, Neoplasm; Gemcitabine; Hemangiosarcoma; Humans; Osteosarcoma; Proteasome Inhibitors; Receptor, IGF Type 1; Sarcoma; Soft Tissue Neoplasms; Taxoids; Tetrahydroisoquinolines; TOR Serine-Threonine Kinases; Trabectedin

2013

Other Studies

1 other study(ies) available for ecteinascidin 743 and Angiosarcoma

Article	Year
Primary breast angiosarcoma - a single institution experience from a tertiary cancer center in South India. Breast disease, 2018, Volume: 37, Issue:3 Topics: Adult; Breast; Breast Neoplasms; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Dioxoles; Female; Hemangiosarcoma; Humans; India; Middle Aged; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Taxoids; Tertiary Care Centers; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome	2018

Article

Year

Primary breast angiosarcoma - a single institution experience from a tertiary cancer center in South India.

Breast disease, 2018, Volume: 37, Issue:3

Topics: Adult; Breast; Breast Neoplasms; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Dioxoles; Female; Hemangiosarcoma; Humans; India; Middle Aged; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Taxoids; Tertiary Care Centers; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome

2018